Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Linli Li

Showing results (91-100 of 137) with videos related to

Pageof 14
Sort By:
Bioactive Materials|May 1, 2023
3D-printed scaffolds with 2D hetero-nanostructures and immunomodulatory cytokines provide pro-healing microenvironment for enhanced bone regenerationXifeng Liu, Bipin Gaihre, Sungjo Park, et al.
Journal of Medicinal Chemistry|September 3, 2024
Structural Optimization and Structure-Activity Relationship of 1<i>H</i>-Pyrazole-4-carboxylic Acid Derivatives as DNA 6mA Demethylase ALKBH1 Inhibitors and Their Antigastric Cancer ActivityFeng Li, Liang Xiong, Jian Zhang, et al.
Journal of Medicinal Chemistry|November 7, 2019
Discovery of 4<i>H</i>-Chromen-4-one Derivatives as a New Class of Selective Rho Kinase (ROCK) Inhibitors, which Showed Potent Activity in ex Vivo Diabetic Retinopathy ModelsLanying Zhao, Yueshan Li, Yujiao Wang, et al.
Bioorganic & Medicinal Chemistry Letters|March 4, 2021
Discovery of 3,6-disubstutited-imidazo[1,2-a]pyridine derivatives as a new class of CLK1 inhibitorsYun Zhang, Anjie Xia, Shiyu Zhang, et al.
International Immunopharmacology|December 11, 2023
Discovery of a novel pyroptosis inhibitor acting though modulating glutathionylation to suppress NLRP3-related signal pathwayNenghua Zhou, Yun Zhang, Yan Jiao, et al.
Cancer Science|January 9, 2019
Preclinical pharmacodynamic evaluation of a new Src/FOSL1 inhibitor, LY-1816, in pancreatic ductal adenocarcinomaWei Yang, Lingwei Meng, Kai Chen, et al.
The Journal of Antibiotics|February 14, 2020
1-hydroxy-7-oxolavanducyanin and Δ<sup>7″,8″</sup>-6″-hydroxynaphthomevalin from Streptomyces sp. CPCC 203577Shufen Li, Xinxin Hu, Linli Li, et al.
Aging|April 21, 2021
HucMSC exosome-delivered 14-3-3ζ alleviates ultraviolet radiation-induced photodamage via SIRT1 pathway modulationPeipei Wu, Bin Zhang, Xinye Han, et al.
Angewandte Chemie (International Ed. in English)|November 3, 2025
Unlocking the Critical Role of Noncovalent Interactions Between Alkali Metal Cations and Nitrate in Promoting the Reduction of Nitrate to AmmoniaShuai Qi, Xinbao Chen, Huan He, et al.
Biochemical Pharmacology|April 19, 2024
Identification of a new class of activators of the Hippo pathway with antitumor activity in vitro and in vivoGuifeng Lin, Anjie Xia, Jingxin Qiao, et al.
Pageof 14

Showing results (91-100 of 137) with videos related to

Sort By:
Pageof 14
Bioactive Materials|May 1, 2023
3D-printed scaffolds with 2D hetero-nanostructures and immunomodulatory cytokines provide pro-healing microenvironment for enhanced bone regenerationXifeng Liu, Bipin Gaihre, Sungjo Park, et al.
Journal of Medicinal Chemistry|September 3, 2024
Structural Optimization and Structure-Activity Relationship of 1<i>H</i>-Pyrazole-4-carboxylic Acid Derivatives as DNA 6mA Demethylase ALKBH1 Inhibitors and Their Antigastric Cancer ActivityFeng Li, Liang Xiong, Jian Zhang, et al.
Journal of Medicinal Chemistry|November 7, 2019
Discovery of 4<i>H</i>-Chromen-4-one Derivatives as a New Class of Selective Rho Kinase (ROCK) Inhibitors, which Showed Potent Activity in ex Vivo Diabetic Retinopathy ModelsLanying Zhao, Yueshan Li, Yujiao Wang, et al.
Bioorganic & Medicinal Chemistry Letters|March 4, 2021
Discovery of 3,6-disubstutited-imidazo[1,2-a]pyridine derivatives as a new class of CLK1 inhibitorsYun Zhang, Anjie Xia, Shiyu Zhang, et al.
International Immunopharmacology|December 11, 2023
Discovery of a novel pyroptosis inhibitor acting though modulating glutathionylation to suppress NLRP3-related signal pathwayNenghua Zhou, Yun Zhang, Yan Jiao, et al.
Cancer Science|January 9, 2019
Preclinical pharmacodynamic evaluation of a new Src/FOSL1 inhibitor, LY-1816, in pancreatic ductal adenocarcinomaWei Yang, Lingwei Meng, Kai Chen, et al.
The Journal of Antibiotics|February 14, 2020
1-hydroxy-7-oxolavanducyanin and Δ<sup>7″,8″</sup>-6″-hydroxynaphthomevalin from Streptomyces sp. CPCC 203577Shufen Li, Xinxin Hu, Linli Li, et al.
Aging|April 21, 2021
HucMSC exosome-delivered 14-3-3ζ alleviates ultraviolet radiation-induced photodamage via SIRT1 pathway modulationPeipei Wu, Bin Zhang, Xinye Han, et al.
Angewandte Chemie (International Ed. in English)|November 3, 2025
Unlocking the Critical Role of Noncovalent Interactions Between Alkali Metal Cations and Nitrate in Promoting the Reduction of Nitrate to AmmoniaShuai Qi, Xinbao Chen, Huan He, et al.
Biochemical Pharmacology|April 19, 2024
Identification of a new class of activators of the Hippo pathway with antitumor activity in vitro and in vivoGuifeng Lin, Anjie Xia, Jingxin Qiao, et al.
Pageof 14